CAS 262438-43-7

ATN-161

Description:

ATN-161, with the CAS number 262438-43-7, is a synthetic peptide that has garnered attention in the field of biomedical research, particularly for its potential therapeutic applications. This compound is known for its ability to inhibit the interaction between specific proteins, which can influence various biological processes, including cell migration and inflammation. ATN-161 is often studied for its implications in conditions such as cancer and fibrosis, where abnormal cell behavior plays a critical role. The peptide is characterized by its relatively small size, which allows for efficient cellular uptake and bioactivity. Additionally, ATN-161 has been shown to exhibit a favorable safety profile in preliminary studies, making it a candidate for further investigation in clinical settings. Its mechanism of action involves modulation of signaling pathways, which can lead to altered cellular responses. Overall, ATN-161 represents a promising area of research in therapeutic development, although further studies are necessary to fully elucidate its efficacy and safety in humans.

ATN-161

CAS: 262438-43-7

Formula: C₂₃H₃₅N₉O₈S

Purity: 98%

Color and Shape: Solid

Molecular weight: 597.6445

Ref: IN-DA00BF27

(S)-2-((R)-2-((S)-2-((S)-2-((S)-1-Acetylpyrrolidine-2-carboxamido)-3-(1H-imidazol-4-yl)propanamido)-3-hydroxypropanamido)-3-mercaptopropanamido)succinamide

CAS: 262438-43-7

(S)-2-((R)-2-((S)-2-((S)-2-((S)-1-Acetylpyrrolidine-2-carboxamido)-3-(1H-imidazol-4-yl)propanamido)-3-hydroxypropanamido)-3-mercaptopropanamido)succinamide

Purity: 98%

Molecular weight: 597.66g/mol

Ref: 54-OR1063728

ATN 161

CAS: 262438-43-7

ATN 161 is a small molecule with anti-cancer properties. It binds to the Mcl-1 protein and inhibits its ability to bind to the integrin receptor, which is required for metastasis. ATN 161 has been shown to be active in animal models of metastatic colorectal cancer and solid tumours, as well as against breast cancer cells. ATN 161 also inhibits metabolic disorders such as bowel disease and polymerase chain reactions that are associated with tumour progression. The drug has been evaluated in vivo in a model of bowel disease and was found to have significant therapeutic effects.

Formula: C₂₃H₃₅N₉O₈S

Purity: Min. 95%

Molecular weight: 597.65 g/mol

Ref: 3D-MKA43843

ATN-161

CAS: 262438-43-7

ATN-161 is an integrin α5β1 binding peptide and antagonist that inhibits VEGF-induced hCECs migration and angiogenesis.

Formula: C₂₃H₃₅N₉O₈S

Purity: 98%

Color and Shape: Solid

Molecular weight: 597.64

Ref: TM-T10398